Better Therapeutics, Inc. (BTTX)
NASDAQ: BTTX · IEX Real-Time Price · USD
1.47
-0.07 (-4.55%)
At close: May 20, 2022 4:00 PM
1.46
-0.01 (-0.68%)
After-hours:May 20, 2022 7:56 PM EDT
Ratios and Metrics (Quarterly)
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Quarter Ended | Current | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 |
---|---|---|---|---|---|---|
Market Capitalization | 35 | 47 | 110 | 75 | 75 | 75 |
Market Cap Growth | - | -38.02% | - | - | - | - |
Enterprise Value | 13 | 25 | 79 | 111 | 101 | 75 |
PE Ratio | - | -1.06 | -2.72 | -2.53 | -3.85 | -6.38 |
PS Ratio | - | - | - | -9.00 | -10.00 | -18.00 |
PB Ratio | 1.27 | 1.70 | 2.99 | -1.31 | -1.67 | - |
Debt / Equity Ratio | 0.35 | 0.35 | 0.26 | -0.68 | -0.62 | 0 |
Current Ratio | 9.86 | 9.86 | 9.56 | 1.14 | 1.44 | - |
Earnings Yield | -127.58% | -20.67% | -11.58% | -17.07% | -12.06% | -7.58% |
FCF Yield | - | -19.03% | -14.87% | -9.14% | - | -4.24% |
Buyback Yield / Dilution | -119.12% | -119.12% | -30.48% | -3.72% | -5.13% | - |
Total Shareholder Return | -119.12% | -119.12% | -30.48% | -3.72% | -5.13% | 0.00% |
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).